Vietnam to test GSK drug for contaminants

In the wake of a recall in Hong Kong, GlaxoSmithKline's ($GSK) antibiotic Augmentin is now facing testing by regulators in Vietnam. The Drug Administration of Vietnam says it will collect samples of the drug to test for plasticizers, the chemicals found in trace amounts by Hong Kong officials. Vietnam has also asked GSK to work with distributors to collect samples.

Hong Kong has pulled two Augmentin products: a powdered form that's reconstituted into a liquid for dosing and a 375 mg pill version. Authorities there said they had found plasticizers in both products; the pill version contained di-2-ethyl hexyl phthalate (DEHP) and diisodecyl phthalate (DIDP). The 375 mg pill is no longer imported into Vietnam, authorities there said, although other pill strengths and powdered versions are.

At the time of the Hong Kong recall, GSK and health officials there emphasized that the amounts of plasticizer found weren't likely to cause harm to humans if they were taken at the proper doses. But Hong Kong is still mulling legal action against the drugmaker. Meanwhile, GSK is conducting an internal investigation to determine the source of the chemicals, because they are not used to manufacture the antibiotic products.

- read the story in Thanh Nien News

Related Articles
Hong Kong forces second GSK recall
Hong Kong yanks GSK drug on phthalate levels 

Suggested Articles

Six pharmaceutical execs are set to head to Washington next week for pricing hearings at the House Committee on Oversight and Reform. 

After sifting through the data, one analyst figures the latest Opdivo-Keytruda showdown in kidney cancer might come down to commercial execution.

Biogen is giving former chief finance officer Jeff Capello a multimillion-dollar cash payment plus other severance benefits.